EE9800435A - H+, K+-ATPaasi inhibiitorite manustamise reziim - Google Patents

H+, K+-ATPaasi inhibiitorite manustamise reziim

Info

Publication number
EE9800435A
EE9800435A EE9800435A EE9800435A EE9800435A EE 9800435 A EE9800435 A EE 9800435A EE 9800435 A EE9800435 A EE 9800435A EE 9800435 A EE9800435 A EE 9800435A EE 9800435 A EE9800435 A EE 9800435A
Authority
EE
Estonia
Prior art keywords
administration
mode
atpase
atpase inhibitors
extended
Prior art date
Application number
EE9800435A
Other languages
English (en)
Other versions
EE04606B1 (et
Inventor
Cederberg Christer
Sachs George
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9800435A publication Critical patent/EE9800435A/et
Publication of EE04606B1 publication Critical patent/EE04606B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
EE9800435A 1996-06-20 1997-06-18 H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks EE04606B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals
PCT/SE1997/001098 WO1997048380A1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS

Publications (2)

Publication Number Publication Date
EE9800435A true EE9800435A (et) 1999-06-15
EE04606B1 EE04606B1 (et) 2006-04-17

Family

ID=20403092

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800435A EE04606B1 (et) 1996-06-20 1997-06-18 H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks

Country Status (27)

Country Link
US (4) US20010008900A1 (et)
EP (1) EP0921787B1 (et)
JP (1) JP2000512993A (et)
CN (1) CN1178648C (et)
AT (1) ATE252885T1 (et)
AU (1) AU726859B2 (et)
BR (1) BR9709838A (et)
CA (1) CA2257405A1 (et)
CZ (1) CZ298213B6 (et)
DE (1) DE69725860T2 (et)
DK (1) DK0921787T3 (et)
EE (1) EE04606B1 (et)
ES (1) ES2208921T3 (et)
HU (1) HUP9901794A3 (et)
IL (2) IL127542A0 (et)
IS (1) IS2216B (et)
NO (1) NO323295B1 (et)
NZ (1) NZ332990A (et)
PL (1) PL189716B1 (et)
PT (1) PT921787E (et)
RS (1) RS49590B (et)
RU (1) RU2203662C2 (et)
SE (1) SE9602442D0 (et)
SK (1) SK284204B6 (et)
TR (1) TR199802647T2 (et)
UA (1) UA64715C2 (et)
WO (1) WO1997048380A1 (et)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
WO1999055158A1 (en) * 1998-04-30 1999-11-04 Sepracor Inc. S-rabeprazole compositions and methods
AU3870599A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. R-rabeprazole compositions and methods
ES2192394T3 (es) 1998-08-10 2003-10-01 Winston Pharmateuticals Llc Profarmacos de inhibidores de la bomba de protones.
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
US7041313B1 (en) 1998-08-12 2006-05-09 Altana Pharma Ag Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
CA2161256C (en) * 1993-04-27 2004-06-29 Nancy M. Gray Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
DK1078628T3 (da) * 1994-07-08 2009-02-23 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Also Published As

Publication number Publication date
EP0921787B1 (en) 2003-10-29
HK1018590A1 (en) 1999-12-30
US20070276007A1 (en) 2007-11-29
PL189716B1 (pl) 2005-09-30
WO1997048380A1 (en) 1997-12-24
US20090036494A1 (en) 2009-02-05
YU56698A (sh) 2004-12-31
DE69725860D1 (de) 2003-12-04
SE9602442D0 (sv) 1996-06-20
CZ420398A3 (cs) 2000-02-16
BR9709838A (pt) 1999-08-10
NO985964L (no) 1999-02-22
IL127542A0 (en) 1999-10-28
ATE252885T1 (de) 2003-11-15
NO985964D0 (no) 1998-12-18
HUP9901794A3 (en) 2002-11-28
PL330910A1 (en) 1999-06-07
TR199802647T2 (xx) 1999-03-22
EP0921787A1 (en) 1999-06-16
IL127542A (en) 2006-08-01
CN1178648C (zh) 2004-12-08
ES2208921T3 (es) 2004-06-16
PT921787E (pt) 2004-03-31
AU3469097A (en) 1998-01-07
US20050113418A1 (en) 2005-05-26
NO323295B1 (no) 2007-03-05
IS4923A (is) 1998-12-15
DE69725860T2 (de) 2004-09-09
AU726859B2 (en) 2000-11-23
HUP9901794A2 (hu) 2000-04-28
UA64715C2 (en) 2004-03-15
SK165598A3 (en) 1999-08-06
NZ332990A (en) 2000-07-28
EE04606B1 (et) 2006-04-17
IS2216B (is) 2007-03-15
CN1222074A (zh) 1999-07-07
CZ298213B6 (cs) 2007-07-25
JP2000512993A (ja) 2000-10-03
CA2257405A1 (en) 1997-12-24
DK0921787T3 (da) 2004-02-23
SK284204B6 (sk) 2004-10-05
RU2203662C2 (ru) 2003-05-10
RS49590B (sr) 2007-06-04
US20010008900A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
DK0921787T3 (da) Indgivelsesdosering af H+, K+ -ATPase-inhibitorer
SE9704870D0 (sv) New pharmaceutical formulation I
SE9504661D0 (sv) New compounds
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
PL350967A1 (en) Pharmaceutical compounds
MY132705A (en) Novel compounds with analgesic effect
IT1285770B1 (it) Composti corticoidei
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
DE69033970D1 (de) Huperzin a analoge verbindungen
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
NO20013414D0 (no) Ny anvendelse av melagatran
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
FI973184A7 (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibi ittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdoll isesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
PT880520E (pt) Derivados da benzo¬c|quinolizina sua preparacao e uso como inibidores da 5-alfa-reductase
SE9504662D0 (sv) New compounds
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AU7470098A (en) Antithrombotic agents
AR004330A1 (es) Uso de inhibidores de colinesterasa en el tratamiento de xerostomia
NO992225L (no) FremgangsmÕte for fremstilling av salter og estere av klavulansyre
DE69430074D1 (de) Analgetische 4-arylisoindolen
DE69824410D1 (en) Antithrombosemittel

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100618